Government to face another high price of new leukemia drug

Published: 2008-04-25 06:59:00

Updated: 2008-04-25 06:59:00

The government will likely in a dilemma to determine the price of Tasigna, another leukemia drug produced by Novartis, as its Korean affiliate has applied to the Health Insurance Review Agency for a price evaluation.

Novartis Korea is trying to get 35,000-39,000 won per pill. Now it is up to t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK